Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT00707876
PHASE2

Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)

Sponsor: AMAG Pharmaceuticals, Inc.

View on ClinicalTrials.gov

Summary

The purpose of this study is to compare the difference between two magnetic resonance imaging (MRI) techniques for visualizing arteries. The study hypothesizes that one method that relies upon imaging flowing blood in the pelvic and leg arteries will not be as accurate or efficient as injecting a safe imaging agent to change the appearance of the blood on the MRI. Both methods will be compared with Digital Subtraction Angiography (DSA).

Official title: Phase II, Open Label, Randomized, Multicenter Trial Comparing Noncontrast MRA vs. Ferumoxytol Vascular Enhanced MRI for Detection of Stenosis or Occlusion of the Aortoiliac and Superficial Femoral Arteries in PAD Subjects Scheduled for DSA

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

119

Start Date

2008-09-01

Completion Date

2020-08-15

Last Updated

2026-04-16

Healthy Volunteers

No

Interventions

DRUG

ferumoxytol

1.0 mg/kg IV ferumoxytol

DRUG

ferumoxytol

2.5 mg/kg IV ferumoxytol

DRUG

ferumoxytol

4.0 mg/kg IV ferumoxytol

Locations (1)

Lexington, Massachusetts, United States